• news.cision.com/
  • Eevia Health/
  • Eevia Health Plc exhibiting and launching a new sku at a key tradeshow – Supply Side West in Las Vegas

Eevia Health Plc exhibiting and launching a new sku at a key tradeshow – Supply Side West in Las Vegas

Report this content

Eevia Health Plc (”Eevia” or ”The Company”) is promoting its organic health ingredients by exhibiting at Supply Side West, a premier nutraceutical tradeshow in Las Vegas, USA between 23 and 27 October 2023

 

Eevia Health Plc exhibiting and launching a new sku at a key tradeshow – Supply Side West in Las Vegas

Eevia Health Plc (”Eevia” or ”The Company”) is promoting its organic health ingredients by exhibiting at Supply Side West, a premier nutraceutical tradeshow in Las Vegas, USA between 23 and 27 October 2023

Supply Side West (https://west.supplysideshow.com/en/home.html) is a key event in the global nutraceutical industry. It is held in Las Vegas in the third week of October every year. It boasts 1,400 + companies exhibiting and attracts over 18,000 industry professionals from over 120 countries every year. Over 84% of the visitors say their main objective of attending the show is to source new ingredients and their suppliers.

The show has built a leading position over the last few decades by maintaining a strong focus and high quality, including an extensive seminar program held adjacent to the tradeshow floor. Over 140 hours of education event & insight seminars are focused on the industry's hottest topics and trends.

Eevia is represented by its sales team at its own booth nr 3541 at the show and will during the show launch a new sku (product variant), Feno-Vitis® 50 Organic, which is a lingonberry extract standardized to not less than 50% polyphenols and 10% proanthocyanidins (PACs). Besides PACs, it contains interesting polyphenols such as quercetin and resveratrol. Clinical studies on Lingonbery products indicate metabolic and gut health effects, including insulin and glucose homeostasis. One very intriguing possible effect is that it may modulate fat metabolism reducing the uptake of fat when eating high-fat diets, as demonstrated in separate Swedish and Finnish pre-clinical studies.

This show is a perfect place to meet decision makers and to present our offering to new prospects. This year, Eevia has received significant attention going into the show and for the first time, we have an almost fully booked meeting schedule for the entire show. From this measure, we should have a very good show and good response on our products, including Feno-Vitis 50 Organic,” states Stein Ulve, CEO Eevia Health Plc.

 

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: stein.ulve@eeviahealth.com                      

Telephone: +358 400 22 5967                         

 

 

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.